Exact Mass: 463.0655

Exact Mass Matches: 463.0655

Found 103 metabolites which its exact mass value is equals to given mass value 463.0655, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Adenylsuccinic acid

(2S)-2-({9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-[(phosphonooxy)methyl]oxolan-2-yl]-9H-purin-6-yl}amino)butanedioic acid

C14H18N5O11P (463.074)


Adenylsuccinic acid, also known as adenylosuccinate, succinyladenosine or aspartyl adenylate, belongs to the class of organic compounds known as purine ribonucleoside monophosphates. These are nucleotides consisting of a purine base linked to a ribose to which one monophosphate group is attached. Adenylsuccinic acid is found in all living organisms, ranging from bacteria to plants to animals. Adenylsuccinic acid is an important intermediate in the de novo purine biosynthesis pathway. Specifically, adenylsuccinic acid is an intermediate in the interconversion of purine nucleotides inosine monophosphate (IMP) and adenosine monophosphate (AMP). The enzyme adenylosuccinate synthase carries out the reaction by the addition of aspartate to IMP. This reaction requires the input of energy from a phosphoanhydride bond in the form of guanosine triphosphate (GTP). Adenylsuccinic acid is a substrate least one other important metabolic reaction in purine biosynthesis. In particular, adenylsuccinic acid can be converted into fumaric acid through its interaction with the enzyme known as adenylosuccinate lyase (or adenylosuccinase). Adenylosuccinate lyase deficiency, is a rare autosomal recessive metabolic disorder characterized by the appearance of succinylaminoimidazolecarboxamide riboside (SAICA riboside) and adenylsuccinic acid in cerebrospinal fluid and urine (PMID: 8412002). Adenylosuccinate lyase deficiency presents with varying degrees of psychomotor retardation, autism, muscle wasting, and epilepsy. The exact cause of the symptoms is unknown, but possibilities include not enough purine nucleotide synthesis for cell replication, malfunctioning of the purine nucleotide cycle, and a buildup of substrates to toxic levels. Adenylsuccinic acid is a substrate of the enzyme adenylosuccinase [EC 4.3.2.2] in purine metabolism pathway. The accumulation of adenylsuccinic acid in body fluids occurs due to a deficiency of adenylosuccinase. (KEGG; PMID 8412002) [HMDB] D018377 - Neurotransmitter Agents > D018846 - Excitatory Amino Acids KEIO_ID A037; [MS2] KO008839 KEIO_ID A037; [MS3] KO008840 KEIO_ID A037

   

7-Methylthioheptyl glucosinolate

7-Methylthioheptyl glucosinolate

C15H29NO9S3 (463.1004)


Acquisition and generation of the data is financially supported by the Max-Planck-Society

   

1D-myo-inositol 2-acetamido-2-deoxy-alpha-D-glucopyranoside 3-phosphate

1-O-(2-Acetamido-2-deoxy-alpha-D-glucopyranosyl)-1D-myo-inositol 3-phosphate

C14H26NO14P (463.1091)


   

L 735821

(E)-3-(2,4-dichlorophenyl)-N-[(3R)-1-methyl-2-oxo-5-phenyl-3H-1,4-benzodiazepin-3-yl]prop-2-enamide

C25H19Cl2N3O2 (463.0854)


D002317 - Cardiovascular Agents > D026902 - Potassium Channel Blockers D049990 - Membrane Transport Modulators

   

Pinotin A aglycone

7-(3,4-dihydroxyphenyl)-4,11-dihydroxy-3-(4-hydroxy-3,5-dimethoxyphenyl)-2λ⁴,8-dioxatricyclo[7.3.1.0⁵,¹³]trideca-1(13),2,4,6,9,11-hexaen-2-ylium

C25H19O9 (463.1029)


Pinotin A aglycone is a polyphenol compound found in foods of plant origin (PMID: 20428313)

   

[(3S)-1-Azabicyclo[2.2.2]octan-3-yl] 2-hydroxy-2-(4-iodophenyl)-2-phenylacetate

[(3S)-1-Azabicyclo[2.2.2]octan-3-yl] 2-hydroxy-2-(4-iodophenyl)-2-phenylacetic acid

C21H22INO3 (463.0644)


   

Adenylosuccinic acid

2-[(9-{3,4-dihydroxy-5-[(phosphonooxy)methyl]oxolan-2-yl}-9H-purin-6-yl)amino]butanedioic acid

C14H18N5O11P (463.074)


   

7-methylthioheptyl glucosinolate

({[8-(methylsulphanyl)-1-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]sulphanyl}octylidene]amino}oxy)sulphonic acid

C15H29NO9S3 (463.1004)


7-methylthioheptyl glucosinolate is a member of the class of compounds known as alkylglucosinolates. Alkylglucosinolates are organic compounds containing a glucosinolate moiety that carries an alkyl chain. 7-methylthioheptyl glucosinolate is slightly soluble (in water) and an extremely strong acidic compound (based on its pKa). 7-methylthioheptyl glucosinolate can be found in a number of food items such as macadamia nut (m. tetraphylla), annual wild rice, herbs and spices, and horseradish tree, which makes 7-methylthioheptyl glucosinolate a potential biomarker for the consumption of these food products.

   

Glochidacuminoside D

Glochidacuminoside D

C21H21NO11 (463.1115)


   

6-Methylthio-3-oxohexyl glucosinolate

6-Methylthio-3-oxohexyl glucosinolate

C14H25NO10S3 (463.0641)


   
   

O1-Benzoyl-2-(4-{[3-chloro-5-(trifluoromethyl)-2-pyridyl]methoxy}phenyl)ethanehydroximamide

O1-Benzoyl-2-(4-{[3-chloro-5-(trifluoromethyl)-2-pyridyl]methoxy}phenyl)ethanehydroximamide

C22H17ClF3N3O3 (463.091)


   

Adenylsuccinic acid

Adenylosuccinic acid

C14H18N5O11P (463.074)


   

(Methylsulfanyl)heptyl glucosinolate

(Methylsulfanyl)heptyl glucosinolate

C15H29NO9S3 (463.1004)


Annotation level-3

   

Carboxyltolmetin Glucuronide

Carboxyltolmetin Glucuronide

C21H21NO11 (463.1115)


   

Carboxyltolmetin-3-glucuronide

Carboxyltolmetin-3-glucuronide

C21H21NO11 (463.1115)


   

Chondritinsulfate

(2S,3S,4S,5R,6R)-6-[(2R,3R,4R,5R,6R)-3-acetamido-2,5-dihydroxy-6-sulfooxyoxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylicacid

C13H21NO15S (463.0632)


   

Pinotin A aglycone

7-(3,4-dihydroxyphenyl)-4,11-dihydroxy-3-(4-hydroxy-3,5-dimethoxyphenyl)-2$l^{4},8-dioxatricyclo[7.3.1.0^{5,13}]trideca-1(13),2,4,6,9,11-hexaen-2-ylium

C25H19O9 (463.1029)


   

2-METHOXYETHYL 2-(5-[2-CHLORO-4-(TRIFLUOROMETHYL)PHENOXY]-2-NITROPHENOXY)PROPANOATE

2-METHOXYETHYL 2-(5-[2-CHLORO-4-(TRIFLUOROMETHYL)PHENOXY]-2-NITROPHENOXY)PROPANOATE

C19H17ClF3NO7 (463.0646)


   

N-(5-chloro-2-methylphenyl)-4-[(5-chloro-2-methylphenyl)azo]-3-hydroxynaphthalene-2-carboxamide

N-(5-chloro-2-methylphenyl)-4-[(5-chloro-2-methylphenyl)azo]-3-hydroxynaphthalene-2-carboxamide

C25H19Cl2N3O2 (463.0854)


   

5-[4-benzoyl-2,3-bis[(6-diazonio-5-oxidonaphthalen-1-yl)sulfonyloxy]phenoxy]sulfonyl-2-diazonionaphthalen-1-olate

5-[4-benzoyl-2,3-bis[(6-diazonio-5-oxidonaphthalen-1-yl)sulfonyloxy]phenoxy]sulfonyl-2-diazonionaphthalen-1-olate

C23H15N2O7S+ (463.06)


   
   

1H,1H,2H,2H-Perfluorodecylamine

1H,1H,2H,2H-Perfluorodecylamine

C10H6F17N (463.0229)


   

4-Iodo-2,5-dimethoxy-N-[(2-methoxyphenyl)methyl]benzeneethanamine hydrochloride

4-Iodo-2,5-dimethoxy-N-[(2-methoxyphenyl)methyl]benzeneethanamine hydrochloride

C18H23ClINO3 (463.0411)


   

2-[N-(2-cyanoethyl)-4-[(2,6-dichloro-4-nitrophenyl)azo]-3-methylanilino]ethyl acetate

2-[N-(2-cyanoethyl)-4-[(2,6-dichloro-4-nitrophenyl)azo]-3-methylanilino]ethyl acetate

C20H19Cl2N5O4 (463.0814)


   

2-(2-DI-TERT-BUTYLPHOSPHINE)BIPHENYLPA&

2-(2-DI-TERT-BUTYLPHOSPHINE)BIPHENYLPA&

C22H30O2PPd- (463.1018)


   

chondroitin sulfate

chondroitin sulfate

C13H21NO15S (463.0632)


   

[2-[(2-chlorophenyl)carbamoyl]-4-(2,4-difluorophenyl)phenyl] benzoate

[2-[(2-chlorophenyl)carbamoyl]-4-(2,4-difluorophenyl)phenyl] benzoate

C26H16ClF2NO3 (463.0787)


   

[2-[(3-chlorophenyl)carbamoyl]-4-(2,4-difluorophenyl)phenyl] benzoate

[2-[(3-chlorophenyl)carbamoyl]-4-(2,4-difluorophenyl)phenyl] benzoate

C26H16ClF2NO3 (463.0787)


   

[2-[(4-chlorophenyl)carbamoyl]-4-(2,4-difluorophenyl)phenyl] benzoate

[2-[(4-chlorophenyl)carbamoyl]-4-(2,4-difluorophenyl)phenyl] benzoate

C26H16ClF2NO3 (463.0787)


   

N-(4-chloro-2-methylphenyl)-4-[(4-chloro-2-methylphenyl)azo]-3-hydroxynaphthalene-2-carboxamide

N-(4-chloro-2-methylphenyl)-4-[(4-chloro-2-methylphenyl)azo]-3-hydroxynaphthalene-2-carboxamide

C25H19Cl2N3O2 (463.0854)


   

2-(3-BroMo-biphenyl-3-yl)-4,6-diphenyl-[1,3,5]triazine

2-(3-BroMo-biphenyl-3-yl)-4,6-diphenyl-[1,3,5]triazine

C27H18BrN3 (463.0684)


   

2-(3-bromobiphenyl-4-yl)-4,6-diphenyl-1,3,5-triazine

2-(3-bromobiphenyl-4-yl)-4,6-diphenyl-1,3,5-triazine

C27H18BrN3 (463.0684)


   

2-(3,4-Dihydroxyphenyl)-3-(beta-D-glucopyranuronosyloxy)-5,7-dihydroxy-1-benzopyrylium

2-(3,4-Dihydroxyphenyl)-3-(beta-D-glucopyranuronosyloxy)-5,7-dihydroxy-1-benzopyrylium

C21H19O12 (463.0876)


   

beta-D-Mannopyranosyl azide 3,4,6-triacetate 2-(1,1,1-trifluoromethanesulfonate)

beta-D-Mannopyranosyl azide 3,4,6-triacetate 2-(1,1,1-trifluoromethanesulfonate)

C13H16F3N3O10S (463.0508)


   

CHONDROITIN SULFATE SHARK CARTILAGE(RG)

CHONDROITIN SULFATE SHARK CARTILAGE(RG)

C13H21NO15S (463.0632)


   

1-(diaminomethylidene)-3-[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]urea; 2,4,6-trinitrophenol

1-(diaminomethylidene)-3-[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]urea; 2,4,6-trinitrophenol

C13H17N7O12 (463.0935)


   

Chondroitin 4-sulfate

Chondroitin 4-sulfate

C13H21NO15S (463.0632)


   

2,2:6,2-Terpyridine Platinum(Ii) Chloride

2,2:6,2-Terpyridine Platinum(Ii) Chloride

C15H11ClN3Pt+ (463.0289)


   

3-[[(2,4-Dinitrophenyl)-oxomethyl]amino]benzoic acid [2-(4-methylphenyl)-2-oxoethyl] ester

3-[[(2,4-Dinitrophenyl)-oxomethyl]amino]benzoic acid [2-(4-methylphenyl)-2-oxoethyl] ester

C23H17N3O8 (463.1016)


FM19G11 is a hypoxia-inducible factor-1-alpha (HIF-1α) inhibitor, and it inhibits hypoxia-induced luciferase activity with an IC50 of 80 nM in HeLa cells. FM19G11 modulates other signaling pathways, including mTOR and PI3K/Akt/eNOS, when the HIF-1α pathway is inactivated under normoxic conditions[1][2].

   

[(2R,3S,4R,5R,6R)-5-Acetamido-4,6-dihydroxy-3-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]methyl hydrogen sulfate

[(2R,3S,4R,5R,6R)-5-Acetamido-4,6-dihydroxy-3-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]methyl hydrogen sulfate

C14H25NO14S (463.0996)


   

N-[7-(3-Aminophenyl)-5-methoxy-1,3-benzoxazol-2-YL]-2,5-dichlorobenzenesulfonamide

N-[7-(3-Aminophenyl)-5-methoxy-1,3-benzoxazol-2-YL]-2,5-dichlorobenzenesulfonamide

C20H15Cl2N3O4S (463.016)


   

Aspartyl adenylate

Aspartyl adenylate

C14H18N5O11P (463.074)


D018377 - Neurotransmitter Agents > D018846 - Excitatory Amino Acids

   

quercetin-3-glucoside

quercetin-3-glucoside

C21H19O12- (463.0876)


   
   

1-S-[2-(4-hydroxy-1H-indol-3-yl)-N-(sulfooxy)ethanimidoyl]-1-thio-beta-D-glucopyranose

1-S-[2-(4-hydroxy-1H-indol-3-yl)-N-(sulfooxy)ethanimidoyl]-1-thio-beta-D-glucopyranose

C16H19N2O10S2- (463.0481)


   

2-(3,4-dihydroxyphenyl)-5-hydroxy-4-oxo-7-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-3-olate

2-(3,4-dihydroxyphenyl)-5-hydroxy-4-oxo-7-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-3-olate

C21H19O12- (463.0876)


   

Quercetin 4-O-beta-D-glucoside

Quercetin 4-O-beta-D-glucoside

C21H19O12- (463.0876)


   

[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] (1E)-8-methylsulfanyl-N-sulfooxyoctanimidothioate

[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] (1E)-8-methylsulfanyl-N-sulfooxyoctanimidothioate

C15H29NO9S3 (463.1004)


   

delfinidin-3-O-glucoside

delfinidin-3-O-glucoside

C21H19O12- (463.0876)


   

1-hydroxyglucobrassicin

1-hydroxyglucobrassicin

C16H19N2O10S2- (463.0481)


   

6-Demethyl-chlortetracycline

6-Demethyl-chlortetracycline

C21H20ClN2O8- (463.0908)


   

(4S,4aS,5aS,6S,12aR)-2-carbamoyl-7-chloro-4-(dimethylazaniumyl)-6,10,12a-trihydroxy-3,12-dioxo-4a,5,5a,6-tetrahydro-4H-tetracene-1,11-diolate

(4S,4aS,5aS,6S,12aR)-2-carbamoyl-7-chloro-4-(dimethylazaniumyl)-6,10,12a-trihydroxy-3,12-dioxo-4a,5,5a,6-tetrahydro-4H-tetracene-1,11-diolate

C21H20ClN2O8- (463.0908)


   

(2,3-Dihydroxybenzoylserine)2

(2,3-Dihydroxybenzoylserine)2

C20H19N2O11- (463.0989)


   

Pinotin A aglycone

Pinotin A aglycone

C25H19O9+ (463.1029)


   

4-Hydroxyindol-3-ylmethylglucosinolate

4-Hydroxyindol-3-ylmethylglucosinolate

C16H19N2O10S2- (463.0481)


   

3-[4-[[[4-chloro-3-(trifluoromethyl)anilino]-oxomethyl]amino]phenoxy]-N-methylbenzamide

3-[4-[[[4-chloro-3-(trifluoromethyl)anilino]-oxomethyl]amino]phenoxy]-N-methylbenzamide

C22H17ClF3N3O3 (463.091)


   

beta-D-Galp6S-(1->4)-beta-D-GlcpNAc

beta-D-Galp6S-(1->4)-beta-D-GlcpNAc

C14H25NO14S (463.0996)


An amino disaccharide that consists of N-acetyl-beta-D-glucosamine having a 6-O-sulfo-beta-D-galactosyl residue attached at position 4.

   

2-[[6,6-dimethyl-2-(propan-2-ylthio)-5,8-dihydropyrano[2,3]thieno[2,4-b]pyrimidin-4-yl]thio]-N-(2-furanylmethyl)acetamide

2-[[6,6-dimethyl-2-(propan-2-ylthio)-5,8-dihydropyrano[2,3]thieno[2,4-b]pyrimidin-4-yl]thio]-N-(2-furanylmethyl)acetamide

C21H25N3O3S3 (463.1058)


   

beta-D-Galp3S-(1->3-)-beta-D-GlcpNAc

beta-D-Galp3S-(1->3-)-beta-D-GlcpNAc

C14H25NO14S (463.0996)


An amino disaccharide composed of 3-sulfated beta-D-galactose and N-acetyl-beta-D-glucosaminyl residues in beta-(1->3) linkage.

   

9-(3-bromo-4-hydroxyphenyl)-10-phenyl-3,4,5,6,7,9-hexahydro-2H-acridine-1,8-dione

9-(3-bromo-4-hydroxyphenyl)-10-phenyl-3,4,5,6,7,9-hexahydro-2H-acridine-1,8-dione

C25H22BrNO3 (463.0783)


   

N-(1,3-benzodioxol-5-yl)-2-[[4-(4-methoxyphenyl)-6-(trifluoromethyl)-2-pyrimidinyl]thio]acetamide

N-(1,3-benzodioxol-5-yl)-2-[[4-(4-methoxyphenyl)-6-(trifluoromethyl)-2-pyrimidinyl]thio]acetamide

C21H16F3N3O4S (463.0814)


   
   

2-chloro-N-[1-[oxo(10-phenothiazinyl)methyl]-4-piperidinyl]benzamide

2-chloro-N-[1-[oxo(10-phenothiazinyl)methyl]-4-piperidinyl]benzamide

C25H22ClN3O2S (463.1121)


   

Myricetin 3-O-alpha-L-rhamnoside

Myricetin 3-O-alpha-L-rhamnoside

C21H19O12- (463.0876)


   

N-acetyllactosamine-6-sulfate

N-acetyllactosamine-6-sulfate

C14H25NO14S (463.0996)


   

beta-D-Galp3S-(1->3-)-alpha-D-GalpNAc

beta-D-Galp3S-(1->3-)-alpha-D-GalpNAc

C14H25NO14S (463.0996)


An amino disaccharide composed of 3-sulfated beta-D-galactose and N-acetyl-alpha-D-galactosaminyl residues in beta-(1->3) linkage.

   

3-(2,3-dihydroindol-1-ylsulfonyl)-N-(4,6-dimethyl-1,3-benzothiazol-2-yl)benzamide

3-(2,3-dihydroindol-1-ylsulfonyl)-N-(4,6-dimethyl-1,3-benzothiazol-2-yl)benzamide

C24H21N3O3S2 (463.1024)


   

4-amino-N-[2-[[5-bromo-2-[(2-fluorophenyl)methoxy]phenyl]methylamino]ethyl]-1,2,5-oxadiazole-3-carboxamide

4-amino-N-[2-[[5-bromo-2-[(2-fluorophenyl)methoxy]phenyl]methylamino]ethyl]-1,2,5-oxadiazole-3-carboxamide

C19H19BrFN5O3 (463.0655)


   

Gal3S(b1-4)GlcNAc

Gal3S(b1-4)GlcNAc

C14H25NO14S (463.0996)


   

Gal(b1-3)b-GlcNAc6S

Gal(b1-3)b-GlcNAc6S

C14H25NO14S (463.0996)


   

beta-D-Galp3S-(1->4)-beta-D-GlcpNAc

beta-D-Galp3S-(1->4)-beta-D-GlcpNAc

C14H25NO14S (463.0996)


An amino disaccharide that consists of N-acetyl-beta-D-glucosamine having a 3-sulfated beta-D-galactosyl residue attached at position 4.

   

beta-D-Galp4S-(1->4)-beta-D-GlcpNAc

beta-D-Galp4S-(1->4)-beta-D-GlcpNAc

C14H25NO14S (463.0996)


An amino disaccharide that consists of N-acetyl-beta-D-glucosamine having a 4-O-sulfo-beta-D-galactosyl residue attached at position 4.

   

beta-D-Galp6P-(1->4)-beta-D-GlcpNAc

beta-D-Galp6P-(1->4)-beta-D-GlcpNAc

C14H26NO14P (463.1091)


   

beta-D-Galp6S-(1->3)-beta-D-GlcpNAc

beta-D-Galp6S-(1->3)-beta-D-GlcpNAc

C14H25NO14S (463.0996)


   

2-acetamido-2-deoxy-3-O-(6-O-sulfo-beta-D-glucosyl)-beta-D-galactose

2-acetamido-2-deoxy-3-O-(6-O-sulfo-beta-D-glucosyl)-beta-D-galactose

C14H25NO14S (463.0996)


An amino disaccharide consisting of N-acetyl-beta-D-galactosamine having a 6-O-sulfo-beta-D-glucosyl residue attached at the 3-position.

   

6-(N-acetyl-D-glucosaminyl-1-phosphono)-D-mannose

6-(N-acetyl-D-glucosaminyl-1-phosphono)-D-mannose

C14H26NO14P (463.1091)


A mannose phosphate that is D-mannose phosphorylated at position 6 by a N-acetyl-D-glucosaminyl-1-phosphono group. Found in the milk of giant pandas.

   

GlcNAc6S(b1-6)Gal

GlcNAc6S(b1-6)Gal

C14H25NO14S (463.0996)


   

Gal3S(b1-3)GlcNAc

Gal3S(b1-3)GlcNAc

C14H25NO14S (463.0996)


   

Gal6S(b1-4)GlcNAc

Gal6S(b1-4)GlcNAc

C14H25NO14S (463.0996)


   

GlcNAc6S(b1-3)Gal

GlcNAc6S(b1-3)Gal

C14H25NO14S (463.0996)


   

Gal2S(b1-4)GlcNAc

Gal2S(b1-4)GlcNAc

C14H25NO14S (463.0996)


   

Galbeta1-4GlcNAc6Pbeta

Galbeta1-4GlcNAc6Pbeta

C14H26NO14P (463.1091)


   

ManNAc4Pbeta1-4Glcbeta

ManNAc4Pbeta1-4Glcbeta

C14H26NO14P (463.1091)


   

Gal2S(b1-4)b-GlcNAc

Gal2S(b1-4)b-GlcNAc

C14H25NO14S (463.0996)


   

3,4,5-Trihydroxy-6-[2-hydroxy-5-(3,5,7-trihydroxychromenylium-2-yl)phenoxy]oxane-2-carboxylic acid

3,4,5-Trihydroxy-6-[2-hydroxy-5-(3,5,7-trihydroxychromenylium-2-yl)phenoxy]oxane-2-carboxylic acid

C21H19O12+ (463.0876)


   

6-[2-(3,4-Dihydroxyphenyl)-3,5-dihydroxychromenylium-7-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid

6-[2-(3,4-Dihydroxyphenyl)-3,5-dihydroxychromenylium-7-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid

C21H19O12+ (463.0876)


   

delphinidin 3-O-beta-D-galactoside(1-)

delphinidin 3-O-beta-D-galactoside(1-)

C21H19O12- (463.0876)


   

Glc6S(b1-3)b-GlcNAc

Glc6S(b1-3)b-GlcNAc

C14H25NO14S (463.0996)


   

(E)-3-(2,4-dichlorophenyl)-N-[(3R)-1-methyl-2-oxo-5-phenyl-3H-1,4-benzodiazepin-3-yl]prop-2-enamide

(E)-3-(2,4-dichlorophenyl)-N-[(3R)-1-methyl-2-oxo-5-phenyl-3H-1,4-benzodiazepin-3-yl]prop-2-enamide

C25H19Cl2N3O2 (463.0854)


D002317 - Cardiovascular Agents > D026902 - Potassium Channel Blockers D049990 - Membrane Transport Modulators

   

N(6)-(1,2-dicarboxyethyl)-AMP

N(6)-(1,2-dicarboxyethyl)-AMP

C14H18N5O11P (463.074)


The N(6)-(1,2-dicarboxyethyl) derivative of adenosine 5-monophosphate.

   

myricitrin(1-)

myricitrin(1-)

C21H19O12 (463.0876)


A flavonoid oxoanion that is the conjugate base of myricitrin arising from selective deprotonation of the 7-hydroxy group; major species at pH 7.3.

   

quercetin 3-O-beta-D-glucopyranoside(1-)

quercetin 3-O-beta-D-glucopyranoside(1-)

C21H19O12 (463.0876)


A flavonoid oxoanion resulting from the deprotonation of the hydroxy group at position 7 of the flavone moiety of quercetin. The major species at pH 7.3.

   

4-hydroxyglucobrassicin(1-)

4-hydroxyglucobrassicin(1-)

C16H19N2O10S2 (463.0481)


An indolylmethylglucosinolate that is the conjugate base of 4-hydroxyglucobrassicin.

   

CD73-IN-4

CD73-IN-4

C16H23ClN5O7P (463.1024)


CD73-IN-4 is a potent and selective methylenephosphonic acid CD73 inhibitor, with an IC50 of 2.6 nM for human CD73. CD73-IN-4 is potential for the research of cancer immunology[1].

   

6-({2,5-dihydroxy-3-[(1-hydroxyethylidene)amino]-6-(sulfooxy)oxan-4-yl}oxy)-3,4,5-trihydroxyoxane-2-carboxylic acid

6-({2,5-dihydroxy-3-[(1-hydroxyethylidene)amino]-6-(sulfooxy)oxan-4-yl}oxy)-3,4,5-trihydroxyoxane-2-carboxylic acid

C13H21NO15S (463.0632)


   

{[8-(methylsulfanyl)-1-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]sulfanyl}octylidene]amino}oxysulfonic acid

{[8-(methylsulfanyl)-1-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]sulfanyl}octylidene]amino}oxysulfonic acid

C15H29NO9S3 (463.1004)


   

(2s,3s,4s,5r,6r)-6-{[(2r,3r,4r,5r,6r)-2,5-dihydroxy-3-[(1-hydroxyethylidene)amino]-6-(sulfooxy)oxan-4-yl]oxy}-3,4,5-trihydroxyoxane-2-carboxylic acid

(2s,3s,4s,5r,6r)-6-{[(2r,3r,4r,5r,6r)-2,5-dihydroxy-3-[(1-hydroxyethylidene)amino]-6-(sulfooxy)oxan-4-yl]oxy}-3,4,5-trihydroxyoxane-2-carboxylic acid

C13H21NO15S (463.0632)


   

2-[cyano(4-hydroxyphenyl)methoxy]-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl 3,4,5-trihydroxybenzoate

2-[cyano(4-hydroxyphenyl)methoxy]-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl 3,4,5-trihydroxybenzoate

C21H21NO11 (463.1115)


   

(2r,3r,4s,5s,6r)-2-[(s)-cyano(4-hydroxyphenyl)methoxy]-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl 3,4,5-trihydroxybenzoate

(2r,3r,4s,5s,6r)-2-[(s)-cyano(4-hydroxyphenyl)methoxy]-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl 3,4,5-trihydroxybenzoate

C21H21NO11 (463.1115)


   

1-carboxy-4-(4,5-dihydroxy-1-oxidoquinolin-1-ium-2-yl)-3,6-dihydroxy-5-oxo-5h-5λ⁵-phenazin-5-ylium-10-olate

1-carboxy-4-(4,5-dihydroxy-1-oxidoquinolin-1-ium-2-yl)-3,6-dihydroxy-5-oxo-5h-5λ⁵-phenazin-5-ylium-10-olate

C22H13N3O9 (463.0652)


   

[(e)-[8-(methylsulfanyl)-1-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]sulfanyl}octylidene]amino]oxysulfonic acid

[(e)-[8-(methylsulfanyl)-1-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]sulfanyl}octylidene]amino]oxysulfonic acid

C15H29NO9S3 (463.1004)


   

(2r)-2-({9-[(2s,3s,4r,5r)-3,4-dihydroxy-5-[(phosphonooxy)methyl]oxolan-2-yl]purin-6-yl}amino)butanedioic acid

(2r)-2-({9-[(2s,3s,4r,5r)-3,4-dihydroxy-5-[(phosphonooxy)methyl]oxolan-2-yl]purin-6-yl}amino)butanedioic acid

C14H18N5O11P (463.074)